{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:10:45Z","timestamp":1777867845631,"version":"3.51.4"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"DOI":"10.1007\/s11920-026-01675-3","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:33:42Z","timestamp":1777534422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disorders of Gut-Brain Interaction in Eating Disorders: A Review of Management Approaches"],"prefix":"10.1007","volume":"28","author":[{"given":"Sophie R.","family":"Abber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha R.","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Burton-Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"crossref","unstructured":"Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology, 2016.","DOI":"10.1053\/j.gastro.2016.02.032"},{"issue":"6","key":"1675_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S2468-1253(22)00351-X","volume":"8","author":"K Staller","year":"2023","unstructured":"Staller K, Abber SR, Murray HB. The intersection between eating disorders and gastrointestinal disorders: a narrative review and practical guide. Lancet Gastroenterol Hepatol. 2023;8(6):565\u201378.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1675_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.70039","author":"H Mikhael-Moussa","year":"2025","unstructured":"Mikhael-Moussa H, et al. The association of avoidant\/restrictive food intake disorder (ARFID) and neurogastroenterology disorders (including disorders of gut\u2013brain interaction [DGBI]): a scoping review. Neurogastroenterol Motil. 2025. https:\/\/doi.org\/10.1111\/nmo.70039.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"1675_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/erv.2847","volume":"29","author":"V Hanel","year":"2021","unstructured":"Hanel V, Schalla MA, Stengel A. Irritable bowel syndrome and functional dyspepsia in patients with eating disorders-a systematic review. Eur Eat Disord Rev. 2021;29(5):692\u2013719.","journal-title":"Eur Eat Disord Rev"},{"issue":"6","key":"1675_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/eat.23527","volume":"54","author":"CA Wiklund","year":"2021","unstructured":"Wiklund CA, et al. Evaluating disorders of gut-brain interaction in eating disorders. Int J Eat Disord. 2021;54(6):925\u201335.","journal-title":"Int J Eat Disord"},{"issue":"32","key":"1675_CR6","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.3748\/wjg.v18.i32.4379","volume":"18","author":"A Santonicola","year":"2012","unstructured":"Santonicola A, et al. Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J gastroenterology: WJG. 2012;18(32):4379.","journal-title":"World J gastroenterology: WJG"},{"issue":"6","key":"1675_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/eat.23414","volume":"54","author":"HB Murray","year":"2021","unstructured":"Murray HB, et al. Disorders of gut\u2013brain interaction common among outpatients with eating disorders including avoidant\/restrictive food intake disorder. Int J Eat Disord. 2021;54(6):952\u20138.","journal-title":"Int J Eat Disord"},{"issue":"6","key":"1675_CR8","doi-asserted-by":"publisher","first-page":"e14782","DOI":"10.1111\/nmo.14782","volume":"36","author":"MN Almeida","year":"2024","unstructured":"Almeida MN, et al. Gastrointestinal diagnoses in patients with eating disorders: a retrospective cohort study 2010\u20132020. Neurogastroenterol Motil. 2024;36(6):e14782.","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"1675_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/MCG.0000000000001853","volume":"57","author":"I Weeks","year":"2023","unstructured":"Weeks I, et al. The intersection of disorders of gut-brain interaction with avoidant\/restrictive food intake disorder. J Clin Gastroenterol. 2023;57(7):651\u201362.","journal-title":"J Clin Gastroenterol"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"107336","DOI":"10.1016\/j.cct.2023.107336","volume":"134","author":"HB Murray","year":"2023","unstructured":"Murray HB, et al. Brief cognitive-behavioral treatment for avoidant\/restrictive food intake disorder in the context of functional dyspepsia: Study protocol for a feasibility randomized controlled trial. Contemp Clin Trials. 2023;134:107336.","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"1675_CR11","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.cgh.2019.12.030","volume":"18","author":"HB Murray","year":"2020","unstructured":"Murray HB, et al. Frequency of eating disorder pathology among patients with chronic constipation and contribution of gastrointestinal-specific anxiety. Clin Gastroenterol Hepatol. 2020;18(11):2471\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"1675_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-2982.2010.01576.x","volume":"22","author":"C Boyd","year":"2010","unstructured":"Boyd C, Abraham S, Kellow J. Appearance and disappearance of functional gastrointestinal disorders in patients with eating disorders. Neurogastroenterol Motil. 2010;22(12):1279\u201383.","journal-title":"Neurogastroenterol Motil"},{"key":"1675_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fpsyt.2020.00195","volume":"11","author":"C Riedlinger","year":"2020","unstructured":"Riedlinger C, et al. Which symptoms, complaints and complications of the gastrointestinal tract occur in patients with eating disorders? A systematic review and quantitative analysis. Front Psychiatry. 2020;11:195.","journal-title":"Front Psychiatry"},{"issue":"6","key":"1675_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/eat.23555","volume":"54","author":"JE Wildes","year":"2021","unstructured":"Wildes JE, et al. Brain-gut psychotherapies: Promising tools to address gastrointestinal problems in patients with eating disorders. Int J Eat Disord. 2021;54(6):1063\u20137.","journal-title":"Int J Eat Disord"},{"key":"1675_CR15","doi-asserted-by":"crossref","unstructured":"Verdonk C et al. Altered Gastrointestinal Interoception in Anorexia Nervosa Predicts Relapse. medRxiv, 2025.","DOI":"10.1101\/2025.09.16.25335842"},{"issue":"6","key":"1675_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV\u2014functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257\u201361.","journal-title":"Gastroenterology"},{"key":"1675_CR17","unstructured":"Diagnostic and statistical manual of mental disorders (5th ed., text rev.). 2022: American Psychiatric Association."},{"issue":"1","key":"1675_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40337-024-01073-1","volume":"12","author":"SL Sharpe","year":"2024","unstructured":"Sharpe SL. A living experience proposal for the co-occurring diagnosis of avoidant\/restrictive food intake disorder and other eating disorders. J Eat Disorders. 2024;12(1):110.","journal-title":"J Eat Disorders"},{"issue":"1","key":"1675_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbct.2020.10.004","volume":"31","author":"JJ Thomas","year":"2021","unstructured":"Thomas JJ, et al. Cognitive-behavioral therapy for adults with avoidant\/restrictive food intake disorder. J Behav Cogn therapy. 2021;31(1):47\u201355.","journal-title":"J Behav Cogn therapy"},{"key":"1675_CR20","doi-asserted-by":"crossref","unstructured":"Cucinotta U, Romano C, Dipasquale V. A systematic review to manage avoidant\/restrictive food intake disorders in pediatric gastroenterological practice. in Healthcare. MDPI; 2023.","DOI":"10.3390\/healthcare11162245"},{"key":"1675_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/eat.22098","volume":"46","author":"JJ Thomas","year":"2013","unstructured":"Thomas JJ, Hartmann AS, Killgore WD. Non-fat-phobic eating disorders: why we need to investigate implicit associations and neural correlates. Int J Eat Disord. 2013;46:416\u201319. https:\/\/doi.org\/10.1002\/eat.22098.","journal-title":"Int J Eat Disord"},{"issue":"19","key":"1675_CR22","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.3390\/jcm11195833","volume":"11","author":"ML West","year":"2022","unstructured":"West ML, et al. Diet, digestion, and the dietitian: a survey of clinicians\u2019 knowledge, attitudes and practices to advance the treatment of gastrointestinal disturbances in individuals with anorexia nervosa. J Clin Med. 2022;11(19):5833.","journal-title":"J Clin Med"},{"issue":"1","key":"1675_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40337-022-00731-6","volume":"11","author":"M Atkins","year":"2023","unstructured":"Atkins M, Burton H, Murray, Staller K. Assessment and management of disorders of gut\u2013brain interaction in patients with eating disorders. J Eat Disorders. 2023;11(1):20.","journal-title":"J Eat Disorders"},{"issue":"7","key":"1675_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ueg2.12617","volume":"12","author":"T van Gils","year":"2024","unstructured":"van Gils T, et al. Symptom profiles compatible with disorders of gut-brain interaction (DGBI) in organic gastrointestinal diseases: A global population\u2010based study. United Eur Gastroenterol J. 2024;12(7):834\u201347.","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"1675_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","volume":"163","author":"L Chang","year":"2022","unstructured":"Chang L, et al. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology. 2022;163(1):118\u201336.","journal-title":"Gastroenterology"},{"issue":"3","key":"1675_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/j.gastro.2023.04.039","volume":"165","author":"B Moshiree","year":"2023","unstructured":"Moshiree B, Drossman D, Shaukat A. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review. Gastroenterology. 2023;165(3):791\u2013e8003.","journal-title":"Gastroenterology"},{"issue":"9","key":"1675_CR27","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.dld.2025.06.012","volume":"57","author":"G Sarnelli","year":"2025","unstructured":"Sarnelli G, et al. Italian guidelines for the diagnosis and treatment of functional dyspepsia - joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG). Dig Liver Dis. 2025;57(9):1730\u201347.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"1675_CR28","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/ajg.2017.154","volume":"112","author":"P Moayyedi","year":"2017","unstructured":"Moayyedi P, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112(7):988\u20131013.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1675_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/apt.16072","volume":"53","author":"AC Ford","year":"2021","unstructured":"Ford AC, et al. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Aliment Pharmacol Ther. 2021;53(1):8\u201321.","journal-title":"Aliment Pharmacol Ther"},{"key":"1675_CR30","doi-asserted-by":"publisher","first-page":"107667","DOI":"10.1016\/j.pharmthera.2020.107667","volume":"217","author":"H Himmerich","year":"2021","unstructured":"Himmerich H, et al. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacol Ther. 2021;217:107667.","journal-title":"Pharmacol Ther"},{"key":"1675_CR31","doi-asserted-by":"crossref","unstructured":"Aziz Q et al. Functional Esophageal Disorders. Gastroenterology, 2016.","DOI":"10.1053\/j.gastro.2016.02.012"},{"issue":"2","key":"1675_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cgh.2014.06.025","volume":"13","author":"PW Weijenborg","year":"2015","unstructured":"Weijenborg PW, et al. Effects of antidepressants in patients with functional esophageal disorders or gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2015;13(2):251\u2013e2591.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1675_CR33","doi-asserted-by":"publisher","first-page":"e14373","DOI":"10.1111\/nmo.14373","volume":"34","author":"Y Luo","year":"2022","unstructured":"Luo Y, Keefer L. The Clinical value of brain-gut behavioral therapies for functional esophageal disorders and symptoms. Neurogastroenterol Motil. 2022;34(6):e14373.","journal-title":"Neurogastroenterol Motil"},{"issue":"32","key":"1675_CR34","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.3748\/wjg.v18.i32.4379","volume":"18","author":"A Santonicola","year":"2012","unstructured":"Santonicola A, et al. Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J Gastroenterol. 2012;18(32):4379\u201385.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1675_CR35","first-page":"157","volume":"17","author":"JA Lin","year":"2021","unstructured":"Lin JA, Woods ER, Bern EM. Common and emergent oral and gastrointestinal manifestations of eating disorders. Gastroenterol Hepatol (N Y). 2021;17(4):157\u201367.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"5","key":"1675_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12328-015-0611-x","volume":"8","author":"Y Sato","year":"2015","unstructured":"Sato Y, Fukudo S. Gastrointestinal symptoms and disorders in patients with eating disorders. Clin J Gastroenterol. 2015;8(5):255\u201363.","journal-title":"Clin J Gastroenterol"},{"issue":"6","key":"1675_CR37","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1053\/j.gastro.2021.01.230","volume":"160","author":"PJ Pasricha","year":"2021","unstructured":"Pasricha PJ, et al. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features. Gastroenterology. 2021;160(6):2006\u201317.","journal-title":"Gastroenterology"},{"issue":"3","key":"1675_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cgh.2021.10.038","volume":"20","author":"BE Lacy","year":"2022","unstructured":"Lacy BE, Tack J, Gyawali CP. AGA clinical practice update on management of medically refractory gastroparesis: expert review. Clin Gastroenterol Hepatol. 2022;20(3):491\u2013500.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1675_CR39","first-page":"127","volume":"74","author":"JW Saleh","year":"1980","unstructured":"Saleh JW, Lebwohl P. Metoclopramide-induced gastric emptying in patients with anorexia nervosa. Am J Gastroenterol. 1980;74(2):127\u201332.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1675_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.physbeh.2012.02.009","volume":"106","author":"MJ Devlin","year":"2012","unstructured":"Devlin MJ, et al. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent. Physiol Behav. 2012;106(2):238\u201342.","journal-title":"Physiol Behav"},{"issue":"4","key":"1675_CR41","doi-asserted-by":"publisher","first-page":"e70100","DOI":"10.1111\/jhn.70100","volume":"38","author":"B Heathcote","year":"2025","unstructured":"Heathcote B, Carey S. Management of Constipation in Eating Disorders-A Scoping Review. J Hum Nutr Diet. 2025;38(4):e70100.","journal-title":"J Hum Nutr Diet"},{"issue":"4","key":"1675_CR42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","volume":"154","author":"DA Drossman","year":"2018","unstructured":"Drossman DA, et al. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140\u2013e11711.","journal-title":"Gastroenterology"},{"issue":"5","key":"1675_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ajg.2017.57","volume":"112","author":"WH Sobin","year":"2017","unstructured":"Sobin WH, Heinrich TW, Drossman DA. Central neuromodulators for treating functional GI disorders: a primer. Am J Gastroenterol. 2017;112(5):693\u2013702.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1675_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.14309\/ajg.0000000000000060","volume":"114","author":"HB Murray","year":"2019","unstructured":"Murray HB, et al. Diagnosis and treatment of rumination syndrome: a critical review. Official J Am Coll Gastroenterology| ACG. 2019;114(4):562\u201378.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"key":"1675_CR45","doi-asserted-by":"crossref","unstructured":"Liu K, et al. Diagnostic and Management Review of Gastric and Supragastric Belching, Aerophagia, and Rumination Syndrome. Clinical Gastroenterology and Hepatology; 2025.","DOI":"10.1016\/j.cgh.2025.08.012"},{"issue":"12","key":"1675_CR46","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.cgh.2021.07.006","volume":"19","author":"L Keefer","year":"2021","unstructured":"Keefer L, Ko CW, Ford AC. AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut-Brain Interaction: Expert Review. Clin Gastroenterol Hepatol. 2021;19(12):2481\u2013e24881.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1675_CR47","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(25)00051-2","volume":"10","author":"M Khasawneh","year":"2025","unstructured":"Khasawneh M, et al. Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(6):537\u201349.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1675_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12664-024-01648-5","volume":"44","author":"S Shanmugham","year":"2025","unstructured":"Shanmugham S, et al. Efficacy of antidepressants in functional dyspepsia: Systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Indian J Gastroenterol. 2025;44(1):24\u201334.","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"1675_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2015-310721","volume":"66","author":"AC Ford","year":"2017","unstructured":"Ford AC, et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66(3):411\u201320.","journal-title":"Gut"},{"issue":"9","key":"1675_CR50","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.dld.2016.05.025","volume":"48","author":"DY Chen","year":"2016","unstructured":"Chen DY, et al. Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus. Dig Liver Dis. 2016;48(9):1012\u20137.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1675_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1067\/mhj.2000.108514","volume":"140","author":"I Varia","year":"2000","unstructured":"Varia I, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J. 2000;140(3):367\u201372.","journal-title":"Am Heart J"},{"issue":"7","key":"1675_CR52","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","volume":"6","author":"LA van Kerkhoven","year":"2008","unstructured":"van Kerkhoven LA, et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2008;6(7):746\u201352. quiz 718.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1675_CR53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2036.2002.01180.x","volume":"16","author":"E Distrutti","year":"2002","unstructured":"Distrutti E, et al. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther. 2002;16(3):613\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1675_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2036.1994.tb00341.x","volume":"8","author":"V Arienti","year":"1994","unstructured":"Arienti V, et al. The effects of levosulpiride on gastric and gall-bladder emptying in functional dyspepsia. Aliment Pharmacol Ther. 1994;8(6):631\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1675_CR55","doi-asserted-by":"publisher","first-page":"e2498","DOI":"10.1002\/brb3.2498","volume":"12","author":"R Han","year":"2022","unstructured":"Han R, Bian Q, Chen H. Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis. Brain Behav. 2022;12(2):e2498.","journal-title":"Brain Behav"},{"issue":"14","key":"1675_CR56","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJMra1515442","volume":"374","author":"RM Navari","year":"2016","unstructured":"Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;374(14):1356\u201367.","journal-title":"N Engl J Med"},{"issue":"6","key":"1675_CR57","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s10620-009-0723-6","volume":"54","author":"M Grover","year":"2009","unstructured":"Grover M, et al. Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci. 2009;54(6):1284\u201391.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1675_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","volume":"14","author":"J Tack","year":"2016","unstructured":"Tack J, et al. Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss. Clin Gastroenterol Hepatol. 2016;14(3):385\u2013e3924.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1675_CR59","doi-asserted-by":"publisher","first-page":"175628482413111","DOI":"10.1177\/17562848241311129","volume":"18","author":"L Cao","year":"2025","unstructured":"Cao L, et al. Randomized clinical trial: the effects of mirtazapine in functional dyspepsia patients. Th Adv Gastroenterol. 2025;18:17562848241311129.","journal-title":"Th Adv Gastroenterol"},{"issue":"1","key":"1675_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13030-021-00205-2","volume":"15","author":"A Khalilian","year":"2021","unstructured":"Khalilian A, et al. A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome. Biopsychosoc Med. 2021;15(1):3.","journal-title":"Biopsychosoc Med"},{"issue":"4","key":"1675_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jaac.2018.01.011","volume":"57","author":"E Gray","year":"2018","unstructured":"Gray E, et al. Mirtazapine and Weight Gain in Avoidant and Restrictive Food Intake Disorder. J Am Acad Child Adolesc Psychiatry. 2018;57(4):288\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 3","key":"1675_CR62","first-page":"421","volume":"31","author":"AF Naviaux","year":"2019","unstructured":"Naviaux AF. Management of ARFID (avoidant restrictive food intake disorder) in a 12-year-old on a paediatric ward in a general hospital: use of mirtazapine, partial hospitalisation model and family based therapy. Psychiatr Danub. 2019;31(Suppl 3):421\u20136.","journal-title":"Psychiatr Danub"},{"issue":"7","key":"1675_CR63","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/eat.24449","volume":"58","author":"A Chishti","year":"2025","unstructured":"Chishti A, et al. Mirtazapine Is Associated With Shorter Hospital Stay in Pediatric Avoidant Restrictive Food Intake Disorder-A Retrospective Chart Review. Int J Eat Disord. 2025;58(7):1345\u201351.","journal-title":"Int J Eat Disord"},{"issue":"11\u201312","key":"1675_CR64","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1365-2036.2008.03849.x","volume":"28","author":"L Van Oudenhove","year":"2008","unstructured":"Van Oudenhove L, et al. Influence of buspirone on gastric sensorimotor function in man. Aliment Pharmacol Ther. 2008;28(11\u201312):1326\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"1675_CR65","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","volume":"10","author":"J Tack","year":"2012","unstructured":"Tack J, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012;10(11):1239\u201345.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"1675_CR66","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/apt.17479","volume":"57","author":"HP Parkman","year":"2023","unstructured":"Parkman HP, et al. Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST). Aliment Pharmacol Ther. 2023;57(11):1272\u201389.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1675_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5056\/jnm24115","volume":"31","author":"Z Mohamedali","year":"2025","unstructured":"Mohamedali Z, et al. Effect of Buspirone on Upper Gastrointestinal Disorders of Gut-Brain Interaction: A Systematic Review and Meta-analysis. J Neurogastroenterol Motil. 2025;31(1):18\u201327.","journal-title":"J Neurogastroenterol Motil"},{"issue":"6","key":"1675_CR68","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/cap.2018.0005","volume":"28","author":"NK Okereke","year":"2018","unstructured":"Okereke NK. Buspirone Treatment of Anxiety in an Adolescent Female with Avoidant\/Restrictive Food Intake Disorder. J Child Adolesc Psychopharmacol. 2018;28(6):425\u20136.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"1675_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MPG.0000000000000964","volume":"62","author":"S Madani","year":"2016","unstructured":"Madani S, Cortes O, Thomas R. Cyproheptadine use in children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2016;62(3):409\u201313.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"1675_CR70","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jpn3.70070","volume":"81","author":"J Groen","year":"2025","unstructured":"Groen J, et al. ESPGHAN\/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4\u201318 years. J Pediatr Gastroenterol Nutr. 2025;81(2):442\u201371.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1675_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.appet.2019.02.012","volume":"137","author":"ME Harrison","year":"2019","unstructured":"Harrison ME, et al. Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review. Appetite. 2019;137:62\u201372.","journal-title":"Appetite"},{"issue":"10","key":"1675_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-017-0590-9","volume":"19","author":"CD Radziwon","year":"2017","unstructured":"Radziwon CD, Lackner JM. Cognitive behavioral therapy for IBS: how useful, how often, and how does it work? Curr Gastroenterol Rep. 2017;19(10):49.","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"1675_CR73","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/eat.23874","volume":"56","author":"H Burton Murray","year":"2023","unstructured":"Burton Murray H, et al. Development of a brief cognitive-behavioral treatment for avoidant\/restrictive food intake disorder in the context of disorders of gut\u2013brain interaction: Initial feasibility, acceptability, and clinical outcomes. Int J Eat Disord. 2023;56(3):616\u201327.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"1675_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jcm7010003","volume":"7","author":"A Halpert","year":"2018","unstructured":"Halpert A. Irritable bowel syndrome: patient-provider interaction and patient education. J Clin Med. 2018;7(1):3.","journal-title":"J Clin Med"},{"key":"1675_CR75","doi-asserted-by":"crossref","unstructured":"Biesiekierski JR, et al. exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome. Volume 56. Alimentary pharmacology & therapeutics; 2022. pp. 592\u2013605. 4.","DOI":"10.1111\/apt.17111"},{"key":"1675_CR76","first-page":"28","volume":"62","author":"EA Mayer","year":"2001","unstructured":"Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry. 2001;62:28\u201337.","journal-title":"J Clin Psychiatry"},{"issue":"6\u20137","key":"1675_CR77","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.brat.2011.04.001","volume":"49","author":"MG Craske","year":"2011","unstructured":"Craske MG, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49(6\u20137):413\u201321.","journal-title":"Behav Res Ther"},{"key":"1675_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.70037","author":"EC Adler","year":"2025","unstructured":"Adler EC, et al. Gut-directed hypnotherapy for irritable bowel syndrome: a systematic review and meta\u2010analysis. Neurogastroenterol Motil. 2025. https:\/\/doi.org\/10.1111\/nmo.70037.","journal-title":"Neurogastroenterol Motil"},{"issue":"10","key":"1675_CR79","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gut.2006.095489","volume":"55","author":"O Palsson","year":"2006","unstructured":"Palsson O, Whitehead W. Hypnosis for non-cardiac chest pain. Gut. 2006;55(10):1381\u20134.","journal-title":"Gut"},{"issue":"11","key":"1675_CR80","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1136\/gut.2007.132621","volume":"56","author":"V Miller","year":"2007","unstructured":"Miller V, Jones H, Whorwell P. Hypnotherapy for non-cardiac chest pain: long-term follow-up. Gut. 2007;56(11):1643\u20131643.","journal-title":"Gut"},{"issue":"10","key":"1675_CR81","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1136\/gut.2005.086694","volume":"55","author":"H Jones","year":"2006","unstructured":"Jones H, et al. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut. 2006;55(10):1403\u20138.","journal-title":"Gut"},{"issue":"7","key":"1675_CR82","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s10620-021-07183-z","volume":"67","author":"SW Kinsinger","year":"2022","unstructured":"Kinsinger SW, et al. Pilot study of a self-administered hypnosis intervention for functional dyspepsia. Dig Dis Sci. 2022;67(7):3017\u201325.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1675_CR83","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert EL, et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002;123(6):1778\u201385.","journal-title":"Gastroenterology"},{"issue":"8","key":"1675_CR84","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1365-2036.2006.02881.x","volume":"23","author":"G Chiarioni","year":"2006","unstructured":"Chiarioni G, et al. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23(8):1241\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"1675_CR85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1442-2050.2010.01064.x","volume":"23","author":"J Kiebles","year":"2010","unstructured":"Kiebles J, et al. Do patients with globus sensation respond to hypnotically assisted relaxation therapy? A case series report. Dis Esophagus. 2010;23(7):545\u201353.","journal-title":"Dis Esophagus"},{"issue":"5","key":"1675_CR86","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/dote.12353","volume":"29","author":"ME Riehl","year":"2016","unstructured":"Riehl ME, et al. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn. Dis Esophagus. 2016;29(5):490\u20136.","journal-title":"Dis Esophagus"},{"issue":"11","key":"1675_CR87","doi-asserted-by":"publisher","first-page":"p1104","DOI":"10.1111\/apt.13202","volume":"41","author":"S Peters","year":"2015","unstructured":"Peters S, Muir J, Gibson P. gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(11):p1104\u20131115.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1675_CR88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/00029157.2012.658531","volume":"55","author":"D Kraft","year":"2012","unstructured":"Kraft D. Comment on Zimmerman\u2019s Use of the River Metaphor in Irritable Bowel Syndrome Treatment. Am J Clin Hypn. 2012;55(2):160\u20137.","journal-title":"Am J Clin Hypn"},{"issue":"3","key":"1675_CR89","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10484-009-9125-y","volume":"35","author":"M Shinozaki","year":"2010","unstructured":"Shinozaki M, et al. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2010;35(3):189\u201398.","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"1","key":"1675_CR90","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","volume":"162","author":"L Keefer","year":"2022","unstructured":"Keefer L, et al. A Rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction. Gastroenterology. 2022;162(1):300\u201315.","journal-title":"Gastroenterology"},{"issue":"3","key":"1675_CR91","doi-asserted-by":"publisher","first-page":"e14926","DOI":"10.1111\/nmo.14926","volume":"37","author":"SW Porges","year":"2025","unstructured":"Porges SW. Disorders of gut\u2013brain interaction through the lens of polyvagal theory. Neurogastroenterol Motil. 2025;37(3):e14926.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"1675_CR92","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/nmo.12737","volume":"28","author":"M Halland","year":"2016","unstructured":"Halland M, et al. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterology Motil. 2016;28(3):384\u201391.","journal-title":"Neurogastroenterology Motil"},{"issue":"10","key":"1675_CR93","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s10620-020-06685-6","volume":"66","author":"HB Murray","year":"2021","unstructured":"Murray HB, et al. Comprehensive cognitive-behavioral interventions augment diaphragmatic breathing for rumination syndrome: a proof-of-concept trial. Dig Dis Sci. 2021;66(10):3461\u20139.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"1675_CR94","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1111\/j.1572-0241.2006.00801.x","volume":"101","author":"DK Chitkara","year":"2006","unstructured":"Chitkara DK, et al. Teaching diaphragmatic breathing for rumination syndrome. Official J Am Coll Gastroenterology| ACG. 2006;101(11):2449\u201352.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"3","key":"1675_CR95","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cgh.2017.10.038","volume":"16","author":"AM-L Ong","year":"2018","unstructured":"Ong AM-L, et al. Diaphragmatic breathing reduces belching and proton pump inhibitor refractory gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol. 2018;16(3):407\u201316. e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"1675_CR96","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/eat.22566","volume":"49","author":"JJ Thomas","year":"2016","unstructured":"Thomas JJ, Murray HB. Cognitive-behavioral treatment of adult rumination behavior in the setting of disordered eating: a single case experimental design. Int J Eat Disord. 2016;49(10):967\u201372.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"1675_CR97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/1098-108X(198601)5:1<169::AID-EAT2260050118>3.0.CO;2-5","volume":"5","author":"JS Mizes","year":"1986","unstructured":"Mizes JS, Fleece EL. On the use of progressive relaxation in the treatment of bulimia: a single-subject design study. Int J Eat Disord. 1986;5(1):169\u201376.","journal-title":"Int J Eat Disord"},{"issue":"2","key":"1675_CR98","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1078390317711250","volume":"24","author":"J Dunne","year":"2018","unstructured":"Dunne J. Mindfulness in anorexia nervosa: an integrated review of the literature. J Am Psychiatr Nurses Assoc. 2018;24(2):109\u201317.","journal-title":"J Am Psychiatr Nurses Assoc"},{"issue":"8","key":"1675_CR99","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/eat.20552","volume":"41","author":"JR Shapiro","year":"2008","unstructured":"Shapiro JR, et al. Exploratory study to decrease postprandial anxiety: just relax! Int J Eat Disord. 2008;41(8):728\u201333.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"1675_CR100","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.brat.2006.07.003","volume":"45","author":"EB Blanchard","year":"2007","unstructured":"Blanchard EB, et al. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther. 2007;45(4):633\u201348.","journal-title":"Behav Res Ther"},{"issue":"3","key":"1675_CR101","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.brat.2005.01.003","volume":"44","author":"EB Blanchard","year":"2006","unstructured":"Blanchard EB, et al. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy. Behav Res Ther. 2006;44(3):317\u201337.","journal-title":"Behav Res Ther"},{"issue":"4","key":"1675_CR102","doi-asserted-by":"publisher","first-page":"668","DOI":"10.14309\/ajg.0000000000001664","volume":"117","author":"S Kikuchi","year":"2022","unstructured":"Kikuchi S, et al. Group cognitive-behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: A randomized controlled trial. Official J Am Coll Gastroenterology| ACG. 2022;117(4):668\u201377.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"key":"1675_CR103","doi-asserted-by":"publisher","first-page":"673939","DOI":"10.3389\/fpsyt.2021.673939","volume":"12","author":"M Funaba","year":"2021","unstructured":"Funaba M, et al. Hybrid cognitive behavioral therapy with interoceptive exposure for irritable bowel syndrome: A feasibility study. Front Psychiatry. 2021;12:673939.","journal-title":"Front Psychiatry"},{"issue":"2","key":"1675_CR104","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cpsp.12103","volume":"22","author":"JF Boswell","year":"2015","unstructured":"Boswell JF, Anderson LM, Anderson DA. Integration of interoceptive exposure in eating disorder treatment. Clin Psychol Sci Pract. 2015;22(2):194.","journal-title":"Clin Psychol Sci Pract"},{"key":"1675_CR105","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brat.2014.04.006","volume":"58","author":"MG Craske","year":"2014","unstructured":"Craske MG, et al. Maximizing exposure therapy: An inhibitory learning approach. Behav Res Ther. 2014;58:10\u201323.","journal-title":"Behav Res Ther"},{"key":"1675_CR106","doi-asserted-by":"publisher","first-page":"101851","DOI":"10.1016\/j.cpr.2020.101851","volume":"78","author":"RM Butler","year":"2020","unstructured":"Butler RM, Heimberg RG. Exposure therapy for eating disorders: A systematic review. Clin Psychol Rev. 2020;78:101851.","journal-title":"Clin Psychol Rev"},{"key":"1675_CR107","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cpr.2016.11.001","volume":"51","author":"KT Laird","year":"2017","unstructured":"Laird KT, et al. Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis. Clin Psychol Rev. 2017;51:142\u201352.","journal-title":"Clin Psychol Rev"},{"issue":"10","key":"1675_CR108","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/nu17101744","volume":"17","author":"O Horovitz","year":"2025","unstructured":"Horovitz O. Advancements in the Diagnosis and Treatment of Eating Disorders in Children and Adolescents: Challenges, Progress, and Future Directions. Nutrients. 2025;17(10):1744.","journal-title":"Nutrients"},{"issue":"10","key":"1675_CR109","first-page":"1769","volume":"89","author":"M Camilleri","year":"1980","unstructured":"Camilleri M. Appraisal of medium-and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol. 1994;89(10):1769\u201374.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1675_CR110","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/gut.32.6.615","volume":"32","author":"P Collins","year":"1991","unstructured":"Collins P, et al. Role of the proximal and distal stomach in mixed solid and liquid meal emptying. Gut. 1991;32(6):615\u20139.","journal-title":"Gut"},{"issue":"11","key":"1675_CR111","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S2468-1253(20)30078-9","volume":"5","author":"BN Limketkai","year":"2020","unstructured":"Limketkai BN, et al. Nutritional approaches for gastroparesis. Lancet Gastroenterol Hepatol. 2020;5(11):1017\u201326.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"1675_CR112","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/nmo.12519","volume":"27","author":"C Homko","year":"2015","unstructured":"Homko C, et al. Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis. Neurogastroenterology Motil. 2015;27(4):501\u20138.","journal-title":"Neurogastroenterology Motil"},{"issue":"1","key":"1675_CR113","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2012.373","volume":"108","author":"M Camilleri","year":"2013","unstructured":"Camilleri M, et al. Clinical guideline: management of gastroparesis. Official J Am Coll Gastroenterology| ACG. 2013;108(1):18\u201337.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"5","key":"1675_CR114","first-page":"515","volume":"56","author":"A Okamoto","year":"2002","unstructured":"Okamoto A, et al. A behavior therapy program combined with liquid nutrition designed for anorexia nervosa. J Neuropsychiatry Clin Neurosci. 2002;56(5):515\u201320.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"11","key":"1675_CR115","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.jand.2020.07.014","volume":"120","author":"AN Hackert","year":"2020","unstructured":"Hackert AN, Kniskern MA, Beasley TM. Academy of Nutrition and Dietetics: revised 2020 standards of practice and standards of professional performance for registered dietitian nutritionists (competent, proficient, and expert) in eating disorders. J Acad Nutr Dietetics. 2020;120(11):1902\u201319. e54.","journal-title":"J Acad Nutr Dietetics"},{"key":"1675_CR116","doi-asserted-by":"crossref","unstructured":"Velayuthan S, et al. Nutrition in Disorders of Gut-Brain Interaction and Motility, in Handbook of Clinical and Practical Pediatric Nutrition. Springer; 2025. pp. 643\u201364.","DOI":"10.1007\/978-3-031-97759-6_52"},{"issue":"5","key":"1675_CR117","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/flgastro-2019-101181","volume":"11","author":"P Paine","year":"2020","unstructured":"Paine P, et al. Jejunal feeding: when is it the right thing to do? Frontline Gastroenterol. 2020;11(5):397\u2013403.","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"1675_CR118","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40337-021-00445-1","volume":"9","author":"K Hindley","year":"2021","unstructured":"Hindley K, Fenton C, McIntosh J. A systematic review of enteral feeding by nasogastric tube in young people with eating disorders. J Eat Disorders. 2021;9(1):90.","journal-title":"J Eat Disorders"},{"issue":"2","key":"1675_CR119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1176\/appi.ajp.23180001","volume":"180","author":"C Crone","year":"2023","unstructured":"Crone C, et al. The American Psychiatric Association practice guideline for the treatment of patients with eating disorders. Am J Psychiatry. 2023;180(2):167\u201371.","journal-title":"Am J Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-026-01675-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-026-01675-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-026-01675-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:03:57Z","timestamp":1777547037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-026-01675-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1007\/s11920-026-01675-3","relation":{},"ISSN":["1535-1645"],"issn-type":[{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NS is a key opinion leader for Gi Health Foundation, Ironwood Pharmaceuticals and Kate Farms. SA and MA have no personal or financial conflicts. HBM receives royalties from Oxford University Press for her book on rumination syndrome and from Cambridge University Press for her forthcoming book on functional bowel disorders.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}